"EAN 2025"

This joint symposium with the European Stroke Organisation showed that advances in stroke care are substantial, yet the journey toward optimal patient outcomes is ongoing.

This symposium stressed the importance of timely and accurate first seizure management. The consensus: dedicated first seizure clinics are essential for better outcomes and more efficient care.

by Anne Bruijnes On the third day of the congress, a full room of delegates settled in for the symposium New Therapeutic Roads for Neuromuscular Diseases, expertly steered by session chairs Benedikt Schoser and Kristl Claeys. The brief was ambitious—cover every major therapeutic platform now reshaping… Continue Reading

This fantastic symposium at the EAN Congress 2025, chaired by Prof. Elinor Ben-Menachem and Prof. Maurizio Paciaroni, explored the interactions between neurology and society.

In this special session a group of highly qualified speakers presented the latest breakthroughs in the treatment of neurological diseases.

Former EAN Residents & Research Fellows Section Chair, Giacomo Sferruzza looks back on a year of transformative events for the rapidly growing community.

The Scientific Panel on Movement Disorders Management Group invites you to join us for the excellent movement disorders programme at the upcoming EAN Congress 2025.

Our papers of the month for June are two studies that suggest that transplantation of dopaminergic progenitor cells into the striatum may confer meaningful clinical benefits for patients with Parkinson’s disease.

EAN supports the G7 Canada Brain Economy Summit, a global initiative uniting leaders to position brain health and brain skills as drivers of economic growth, resilience, and cross-sector innovation.

The University of Cyprus in Nicosia was thrilled to host the highly anticipated 9th European Sleep Foundation (ESF) Sleep Medicine School from 31 March to 3 April 2025, endorsed by the EAN.

Our papers of the month for May are two papers present findings from recent trials evaluating the efficacy and safety of tolebrutinib in patients with multiple sclerosis.

The European Commission has released draft details for Horizon Europe’s 2025 Cluster 1 – Health calls, with official publication expected on 22 May 2025. These calls include several funding opportunities of high relevance to the neurology research community.